These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17647166)

  • 21. [The legal aspects of "off label use" -- or: Doubtful private prescription].
    Internist (Berl); 2008 Mar; 49(3):322-7. PubMed ID: 18327518
    [No Abstract]   [Full Text] [Related]  

  • 22. Off-label promotion, on-target sales.
    Fugh-Berman A; Melnick D
    PLoS Med; 2008 Oct; 5(10):e210. PubMed ID: 18959472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Responsibility for patient education in drug therapy from the viewpoint of the drug industry].
    Lerch C
    Z Arztl Fortbild (Jena); 1994 Dec; 88(12):1055-60. PubMed ID: 7716982
    [No Abstract]   [Full Text] [Related]  

  • 24. China's deadly drug problem.
    Cyranoski D
    Nature; 2007 Apr; 446(7136):598-9. PubMed ID: 17410150
    [No Abstract]   [Full Text] [Related]  

  • 25. [Off-label prescriptions. Drug use outside of established guidelines and treatment standard].
    Weissbach L; Boedefeld EA
    Urologe A; 2003 Mar; 42(3):428-32. PubMed ID: 12723544
    [No Abstract]   [Full Text] [Related]  

  • 26. Off-label pharmaceutical use: balancing information, risks, and benefits.
    Kozma CM
    Manag Care Interface; 2004 Jan; 17(1):29-30. PubMed ID: 15035597
    [No Abstract]   [Full Text] [Related]  

  • 27. [Old drugs, new possibilities].
    Raknes G
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):62-5. PubMed ID: 18183061
    [No Abstract]   [Full Text] [Related]  

  • 28. Medical physicists should not encourage or participate in off-label, non-FDA-approved uses of intravascular brachytherapy devices. Against the proposition.
    Amols HI
    Med Phys; 2002 Sep; 29(9):2129-30. PubMed ID: 12349934
    [No Abstract]   [Full Text] [Related]  

  • 29. Medical physicists should not encourage or participate in off-label, non-FDA-approved uses of intravascular brachytherapy devices. For the proposition.
    Jani SK
    Med Phys; 2002 Sep; 29(9):2128-9. PubMed ID: 12349933
    [No Abstract]   [Full Text] [Related]  

  • 30. [Increased legal liability in off-label use].
    Broglie M
    Aktuelle Urol; 2006 Nov; 37(6):417-9. PubMed ID: 17153265
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes at FDA may speed drug approval process and increase off-label use.
    Reh M
    J Natl Cancer Inst; 1998 Jun; 90(11):805-7. PubMed ID: 9625166
    [No Abstract]   [Full Text] [Related]  

  • 32. Indian experts protest against off-label drug use.
    Sharma DC
    Lancet; 2004 Apr; 363(9418):1372. PubMed ID: 15112705
    [No Abstract]   [Full Text] [Related]  

  • 33. The rationale for off-label prescriptions.
    Johns Hopkins Med Lett Health After 50; 2000 May; 12(3):6. PubMed ID: 10798286
    [No Abstract]   [Full Text] [Related]  

  • 34. Off-label prescribing of medications for children.
    Monestime-Williams N; Dickerson LM; Basco WT
    J S C Med Assoc; 2007 Jun; 103(5):130-3. PubMed ID: 18333578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off label use--label off use?
    Boos J
    Ann Oncol; 2003 Jan; 14(1):1-5. PubMed ID: 12488285
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug committees should not recommend "off label" prescriptions].
    Rane A
    Lakartidningen; 2006 Apr 12-25; 103(15-16):1219. PubMed ID: 16696203
    [No Abstract]   [Full Text] [Related]  

  • 37. [Off label drugs and pediatric hematology-oncology practices].
    Le Guyader N; Pouliquen AL; Benoit G; Leverger G
    Arch Pediatr; 2006 Sep; 13(9):1267-8. PubMed ID: 16814531
    [No Abstract]   [Full Text] [Related]  

  • 38. [Unlicensed and off label usage of some drugs in obstetric practice].
    Bozhinova S; Tsvetkov D
    Akush Ginekol (Sofiia); 2008; 47(5):43-7. PubMed ID: 19227775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indian Medical Association wants off-label prescribing.
    Mudur G
    BMJ; 2004 Apr; 328(7446):974. PubMed ID: 15105310
    [No Abstract]   [Full Text] [Related]  

  • 40. Off-base: limitations on Medicare Part D coverage of off-label prescriptions.
    Medicare Rights Center
    Care Manag J; 2008; 9(3):142-8. PubMed ID: 18847098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.